Severe community‑acquired pneumonia caused by <em>Legionella gormanii </em>in combination with influenza A subtype (H1N1) virus in an immunocompetent patient detected by metagenomic next‑generation sequencing: A case report

Li,Sujuan; Zhang,Yuanhang; Han,Dongsheng

doi:10.3892/br.2024.1833

Severe community‑acquired pneumonia caused by Legionella gormanii in combination with influenza A subtype (H1N1) virus in an immunocompetent patient detected by metagenomic next‑generation sequencing: A case report

Authors:
- Sujuan Li
- Yuanhang Zhang
- Dongsheng Han
View Affiliations

Affiliations: Department of Clinical Laboratory, Hangzhou Traditional Chinese Medicine Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310005, P.R. China, Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, P.R. China
Published online on: August 12, 2024 https://doi.org/10.3892/br.2024.1833
Article Number: 145
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Legionella pneumonia is an atypical form of pneumonia caused by Legionella gormanii that can also lead to multiple organ diseases, including acute respiratory distress syndrome and multiple organ dysfunction syndrome. Legionella gormanii requires a long incubation period for culture in clinical practice using BCYE medium. The specificity of serum for serological detection is low, resulting in a relatively high rate of missed Legionella diagnoses. Contracting the H1N1 virus can lead to the misdiagnosis of Legionella gormanii. Metagenomic next‑generation sequencing (mNGS) is a novel tool that can rapidly and accurately identify potential Legionella gormanii strains. A severe case of community‑acquired pneumonia in a 79‑year‑old patient was reported. The patient was diagnosed with Legionella gormanii and influenza A subtype (H1N1) virus using mNGS at The First Affiliated Hospital, Zhejiang University School of Medicine. After anti‑Legionella and antiviral therapy, the number of reads identifying Legionella gormanii in bronchoalveolar lavage fluid using mNGS decreased from 665 to 112 as the patient's condition gradually improved. A search of PubMed revealed few reports of Legionella gormanii in association with the influenza A subtype (H1N1) virus. Patients with severe pneumonia caused by Legionella and influenza A subtype H1N1 virus infections should be screened early for infections using methods such as mNGS. This approach enables early and precise treatment, simplifying the administration of antibiotics and enhancing patient outcomes.

View Figures

View References

1	Torres A, Chalmers JD, Dela Cruz CS, Dominedò C, Kollef M, Martin-Loeches I, Niederman M and Wunderink RG: Challenges in severe community-acquired pneumonia: A point-of-view review. Intensive Care Med. 45:159–171. 2019.PubMed/NCBI View Article : Google Scholar
2	Castillo NE, Rajasekaran A and Ali SK: Legionnaires' disease: A review. Infect Dis Clin Pract. 24(1)2016.
3	Cunha BA, Nausheen S and Busch L: Severe Q fever community-acquired pneumonia (CAP) mimicking Legionnaires' disease: Clinical significance of cold agglutinins, anti-smooth muscle antibodies and thrombocytosis. Heart Lung. 38:354–362. 2009.PubMed/NCBI View Article : Google Scholar
4	Viasus D, Di Yacovo S, Garcia-Vidal C, Verdaguer R, Manresa F, Dorca J, Gudiol F and Carratalà J: Community-acquired legionella pneumophila pneumonia: A single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore). 92:51–60. 2013.PubMed/NCBI View Article : Google Scholar
5	García-Somoza MD, Fernández A, Prats E and Verdaguer R: Community-acquired pneumonia caused by legionella longbeachae serogroup 1 in an immunocompetent patient. Enferm Infecc Microbiol Clín. 28:398–399. 2010.PubMed/NCBI View Article : Google Scholar : (In Spanish).
6	Snelling WJ, Sleator RD, Carrillo CD, Lowery C, Moore JE, Pezacki JP and Dooley J: Current and Emerging Microbiology Issues of Potable Water in Developed Countries. In: Drinking Water: Contamination, Toxicity and Treatment. Molina SP and Romero JD (eds). Nova Science Publishers, pp121-152, 2008.
7	Dagan A, Epstein D, Mahagneh A, Nashashibi J, Geffen Y, Neuberger A and Miller A: Community-acquired versus nosocomial legionella pneumonia: Factors associated with legionella-related mortality. Eur J Clin Microbiol Infect Dis. 40:1419–1426. 2021.PubMed/NCBI View Article : Google Scholar
8	Pérez-Cobas AE, Ginevra C, Rusniok C, Jarraud S and Buchrieser C: Persistent legionnaires' disease and associated antibiotic treatment engender a highly disturbed pulmonary microbiome enriched in opportunistic microorganisms. mBio. 11:e00889–20. 2020.PubMed/NCBI View Article : Google Scholar
9	Pouderoux C, Ginevra C, Descours G, Ranc AG, Beraud L, Boisset S, Magand N, Conrad A, Bergeron-Lafaurie A, Jarraud S and Ader F: Slowly or nonresolving legionnaires' disease: Case series and literature review. Clin Infect Dis. 70:1933–1940. 2020.PubMed/NCBI View Article : Google Scholar
10	David S, Rusniok C, Mentasti M, Gomez-Valero L, Harris SR, Lechat P, Lees J, Ginevra C, Glaser P, Ma L, et al: Multiple major disease-associated clones of legionella pneumophila have emerged recently and independently. Genome Res. 26:1555–1564. 2016.PubMed/NCBI View Article : Google Scholar
11	Han D, Yu F, Zhang D, Yang Q, Shen R, Zheng S and Chen Y: Applicability of bronchoalveolar lavage fluid and plasma metagenomic next-generation sequencing assays in the diagnosis of pneumonia. Open Forum Infect Dis. 11(ofad631)2023.PubMed/NCBI View Article : Google Scholar
12	Han D, Yu F, Zhang D, Yang Q, Xie M, Yuan L, Zheng J, Wang J, Zhou J, Xiao Y, et al: The real-world clinical impact of plasma mNGS testing: An observational study. Microbiol Spectr. 11(e0398322)2023.PubMed/NCBI View Article : Google Scholar : (Epub ahead of print).
13	Fields BS, Benson RF and Besser RE: Legionella and legionnaires' disease: 25 years of investigation. Clin Microbiol Rev. 15:506–526. 2002.PubMed/NCBI View Article : Google Scholar
14	O'Brien SJ and Bhopal RS: Legionnaires' disease: The infective dose paradox. Lancet. 342:5–6. 1993.PubMed/NCBI View Article : Google Scholar
15	Gu W, Miller S and Chiu CY: Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 14:319–338. 2019.PubMed/NCBI View Article : Google Scholar
16	NNDSS Annual Report Writing Group. Australia's notifiable disease status, 2015: Annual report of the national notifiable diseases surveillance system. Commun Dis Intell (2018). 43:2019.PubMed/NCBI View Article : Google Scholar
17	Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, Lortholary O, Zumla A and Abubakar I: Epidemiology and clinical management of legionnaires' disease. Lancet Infect Dis. 14:1011–1021. 2014.PubMed/NCBI View Article : Google Scholar
18	Priest PC, Slow S, Chambers ST, Cameron CM, Balm MN, Beale MW, Blackmore TK, Burns AD, Drinković D, Elvy JA, et al: The burden of legionnaires' disease in New Zealand (LegiNZ): A national surveillance study. Lancet Infect Dis. 19:770–777. 2019.PubMed/NCBI View Article : Google Scholar